Date published: 2025-10-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Wogonin (CAS 632-85-9)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
5,7-Dihydroxy-8-methoxyflavone
Application:
Wogonin is an anti-inflammatory agent and inhibitor of COX-2
CAS Number:
632-85-9
Molecular Weight:
284.26
Molecular Formula:
C16H12O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Wogonin, a flavonoid compound derived from the root of Scutellaria baicalensis, has been extensively studied for its diverse research applications. One of its notable mechanisms of action lies in its ability to modulate various signaling pathways implicated in cellular processes. Research indicates that wogonin exerts its biological effects through the inhibition of key enzymes and transcription factors involved in inflammation, oxidative stress, and cancer progression. Specifically, wogonin has been shown to inhibit the activation of nuclear factor-kappa B (NF-κB) signaling, a central regulator of inflammatory responses, by blocking its nuclear translocation and DNA binding activity. Additionally, wogonin has demonstrated potent antioxidant activity by scavenging reactive oxygen species (ROS) and restoring cellular redox balance. Furthermore, wogonin has emerged as a promising candidate for cancer research due to its ability to induce apoptosis, inhibit cell proliferation, and suppress metastasis in various cancer cell lines and animal models. Beyond its anti-inflammatory and anticancer properties, wogonin has also been investigated for its neuroprotective, cardioprotective, and hepatoprotective effects, highlighting its utility in diverse pathological conditions. Ongoing research continues to unravel the molecular mechanisms underlying the pharmacological actions of wogonin, paving the way for its development as a novel agent and research tool in various scientific disciplines.


Wogonin (CAS 632-85-9) References

  1. Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?  |  Khan, S. and Kamal, MA. 2019. Curr Pharm Des. 25: 2171-2177. PMID: 31298148
  2. Wogonin Influences Osteosarcoma Stem Cell Stemness Through ROS-dependent Signaling.  |  Koh, H., et al. 2020. In Vivo. 34: 1077-1084. PMID: 32354895
  3. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.  |  Liu, XQ., et al. 2022. Acta Pharmacol Sin. 43: 96-110. PMID: 34253875
  4. Wogonin Induces Cell Cycle Arrest and Apoptosis of Hepatocellular Carcinoma Cells by Activating Hippo Signaling.  |  Wu, K., et al. 2022. Anticancer Agents Med Chem. 22: 1551-1560. PMID: 34431466
  5. Wogonin Alleviates Cisplatin-induced Cardiotoxicity in Mice Via Inhibiting Gasdermin D-mediated Pyroptosis.  |  Xu, J., et al. 2021. J Cardiovasc Pharmacol. 78: 597-603. PMID: 34651602
  6. Wogonin and its analogs for the prevention and treatment of cancer: A systematic review.  |  Banik, K., et al. 2022. Phytother Res. 36: 1854-1883. PMID: 35102626
  7. Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway.  |  Zhang, T., et al. 2022. Front Pharmacol. 13: 1068855. PMID: 36618921
  8. Wogonin inhibits latent HIV-1 reactivation by downregulating histone crotonylation.  |  Zhang, H., et al. 2023. Phytomedicine. 116: 154855. PMID: 37172478
  9. Wogonin inhibits hepatoma cell proliferation by targeting miR-27b-5p/YWHAZ axis.  |  Ma, MY., et al. 2023. J Biochem Mol Toxicol. 37: e23508. PMID: 37623816
  10. Wogonin improves colitis by activating the AhR pathway to regulate the plasticity of ILC3/ILC1.  |  Ye, Q., et al. 2024. Phytomedicine. 128: 155425. PMID: 38518634

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Wogonin, 5 mg

sc-216062
5 mg
$144.00

Wogonin, 25 mg

sc-216062A
25 mg
$560.00